Login

Healthcare

00:00:00
Micro-X (ASX:MX1): Peter Rowland, Managing Director, Micro-X Ltd
00:00:00
MicroBix (MBX.T) CEO, Cameron L. Groome, talks antigens
00:00:00
Moberg Pharma | Interview - Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
CEO Anna Ljung presents Moberg Pharma - Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
Anna Ljung, CEO, Moberg Pharma AB (publ)
00:00:00
Eric Poma, CEO of Molecular Templates
00:00:00
US companies set the benchmark for Motif Bio - Graham Lumsden, chief executive of Motif Bio PLC
00:00:00
Miguel Sieler, CEO, Neovacs
00:00:00
Neovasc uses conference to announce positive interim clinical data from Neovasc Reducer use - Bill Little, COO, Neovasc Inc
00:00:00
Mike McCormick President & CEO, Osprey Medical Inc
00:00:00
Update with Orgenesis Inc. (OTCQB: ORGS) | Vered Caplan, CEO, Orgenesis Inc
00:00:00
Orgenesis signs deal with Accellix, invites Academy Award winner on Scientific board - Vered Caplan, CEO, Orgenesis Inc
00:00:00
NetScientific changes "really paying off" - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
What makes CEOs tick?' with Dr Ilian Iliev, CEO of NetScientific - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
NetScientific "well positioned for growth" when venture capital market turns - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific
00:00:00
NetScientific PLC's purchase of interest in Vortex Bio showcases “deep stake” transatlantic strategy - Dr. Ilian Iliev CHIEF EXECUTIVE OFFICER, Netscientific

© 2017 - Townhall + Tv